Lamarque Natalie
Known title: EVP, General Counsel, and SecrCIK: 0001939126
Associated companies
Transaction History
| PFG | ▲ Buy | Grant | 800 | $0 | 6/27/2025 | View on chart |
| PFG | ▲ Buy | Grant | 744 | $0 | 3/28/2025 | View on chart |
| PFG | ▲ Buy | Grant | 5,468 | $0 | 2/24/2025 | View on chart |
| PFG | ▲ Buy | Grant | 744 | $0 | 12/18/2024 | View on chart |
| PFG | ▲ Buy | Grant | 635 | $0 | 9/27/2024 | View on chart |
| PFG | ▲ Buy | Grant | 672 | $0 | 6/28/2024 | View on chart |
| PFG | ▲ Buy | Grant | 597 | $0 | 3/28/2024 | View on chart |
| PFG | ▲ Buy | Grant | 5,533 | $0 | 2/26/2024 | View on chart |
| PFG | ▲ Buy | Grant | 724 | $0 | 12/20/2023 | View on chart |
| PFG | ▲ Buy | Grant | 757 | $0 | 9/29/2023 | View on chart |
| PFG | ▲ Buy | Grant | 702 | $0 | 6/30/2023 | View on chart |
| PFG | ▲ Buy | Grant | 710 | $0 | 3/31/2023 | View on chart |
| PFG | ▲ Buy | Grant | 4,855 | $0 | 2/27/2023 | View on chart |
| PFG | ▲ Buy | Grant | 585 | $0 | 12/19/2022 | View on chart |
| PFG | ▲ Buy | Grant | 677 | $0 | 9/30/2022 | View on chart |
| PFG | ▲ Buy | Grant | 76,370 | $0 | 7/18/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Principal Financial Group (PFG) dividend focus and analyst target update
Recent coverage highlighted PFG’s dividend update, noting its 3.69% yield and suggesting the stock may be undervalued. At the same time, Wells Fargo kept an equal‑weight position but lowered its price target to $113, reflecting a more modest outlook. The company’s trailing P/E of 14.8 and support near $110.9 provide additional context for the discussion.
Principal Financial Group (PFG) dividend focus and analyst target update. Recent coverage highlighted PFG’s dividend update, noting its 3.69% yield and suggesting the stock may be undervalued. At the same time, Wells Fargo kept an equal‑weight position but lowered its price target to $113, reflecting a more modest outlook. The company’s trailing P/E of 14.8 and support near $110.9 provide additional context for the discussion.